Skip to main content
. 2021 Jun 16;12(7):624. doi: 10.1038/s41419-021-03922-2

Fig. 6. OSTN is a promising therapeutic target to treat DCM.

Fig. 6

A, B Cardiac functional parameters (n = 8). C Statistical results of the TUNEL-positive nuclei and collagen deposition (n = 6). D Serum levels of liver enzymes (n = 6). E Relative cGMP levels and PKG activities in heart samples (n = 6). F Cardiac functional parameters (n = 6). Data represent mean ± SD. *P < 0.05 versus the matched group, NS indicates no significance.